Studies have shown that women suffer a higher risk of developing dementia than men. Now, a study reports that this gender difference…
Articles by Magdalena Kegel
In September 2015, a study published in the journal Nature significantly stirred the scientific community and made people around the…
Two previously failed drug candidates, Eli Lilly’s Solanezumab and Roche’s Gantenerumab, are again under clinical study for Alzheimer’s disease.
An editorial by a large number of senior Alzheimer’s researchers urges the scientific community to take a serious look at…
The buildup of amyloid beta plaques in Alzheimer’s disease is believed to result from patients’ inability to break down the protein. But…
Tel Aviv University and Harvard researchers have found a new biomarker for cognitive aging and Alzheimer’s disease (AD).
While there is abundant evidence that seafood consumption protects from the development of dementia, little is known about the effects of…
A study from Tel Aviv University found that the IGF-1 receptor, associated with an increased lifespan in mice, is mediating…
Researchers at the Scintillon Institute for Biomedical and Bioenergy Research, San Diego, have discovered that the high blood sugar levels that mark type…
British researchers recently identified a protein driving brain inflammation, CSF1R, which they think may be the driving force behind the progression of Alzheimer’s disease…